Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Allergan plc | d723375d8k.htm |
Exhibit 99.1
Actavis Pharma Segment Revenue
| (Unaudited; $ in millions) | Three Months Ended March 31, 2014 |
Twelve Months Ended December 31, 2013 |
Three Months Ended December 31, 2013 |
Three Months Ended September 30, 2013 |
Three Months Ended June 30, 2013 |
Three Months Ended March 31, 2013 |
Twelve Months Ended December 31, 2012 |
Twelve Months Ended December 31, 2011 |
||||||||||||||||||||||||
| North American Brands: |
||||||||||||||||||||||||||||||||
| Women’s Health |
$ | 212.6 | $ | 292.8 | $ | 224.6 | $ | 26.9 | $ | 21.3 | $ | 20.0 | $ | 61.9 | $ | 32.5 | ||||||||||||||||
| Urology / Gastroenterology |
225.2 | 408.8 | 236.1 | 60.2 | 55.8 | 56.7 | 217.7 | 209.0 | ||||||||||||||||||||||||
| Dermatology / Established Brands |
156.2 | 360.9 | 174.4 | 65.9 | 67.7 | 52.9 | 198.6 | 190.6 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total North American Brands |
594.0 | 1,062.5 | 635.1 | 153.0 | 144.8 | 129.6 | 478.2 | 432.1 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| North American Generics |
1,024.2 | 3,915.7 | 1,033.1 | 976.1 | 949.8 | 956.7 | 3,472.2 | 2,945.6 | ||||||||||||||||||||||||
| International |
646.7 | 2,502.5 | 728.1 | 576.8 | 619.4 | 578.2 | 978.1 | 430.5 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Net Revenues |
$ | 2,264.9 | $ | 7,480.7 | $ | 2,396.3 | $ | 1,705.9 | $ | 1,714.0 | $ | 1,664.5 | $ | 4,928.5 | $ | 3,808.2 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Our North American Brands Revenue consists of three categories: Women’s Healh, Urology/Gastroenterology, and Dermatology/Established Brands. The products that make up each category are as follows:
| Women’s Health |
Urology/Gastroenterology |
Dermatology/Established Brands | ||||
| Atelvia® | Androderm® | Cordran® Tape | Tri-Norinyl® | |||
| Crinone® | Asacol® | Doryx® | Oxytrol® | |||
| Estrace® Cream | Asacol® HD/Asacol® 800 | Actonel® | Gelnique® | |||
| Generess® Fe | Delzicol® | Actonel DR® | Sodium Ferric Gluconate | |||
| Lo Loestrin® Fe | Enablex® | INFeD® | Actigall® | |||
| Loestrin® 24 Fe | Rapaflo® | Kadian® | Condylox® | |||
| Minastrin® 24 Fe | Trelstar® | Alora® | Fioricet® | |||
| Fibristal™ | AndroGel® Copromotion Revenue | Brevicon® | Fiorinal® | |||
| ella® | Norco® | |||||
| Estrace® Tablets | Microzide® | |||||
| Femring® | Femcon® Fe | |||||
| Norinyl® | femhrt® | |||||
| Nor-QD® | Sarafem® | |||||
| PapSure® | Estrostep® Fe | |||||
| PreQue 10™ | Ovcon® | |||||
| Royalty, Supply & Other Revenue | ||||||